Download Files:
DCPLA-ME
SKU
HY-108599A-1 mg
Category Reference compound
Tags Epigenetics;TGF-beta/Smad, Neurological Disease, PKC
$166 – $2,250
Products Details
Product Description
– DCPLA-ME, the methyl ester form of DCPLA, is a potent PKCε activator for use in the treatment of neurodegenerative diseases[1].
Web ID
– HY-108599A
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Neuroscience-Neurodegeneration
Molecular Formula
– C21H38O2
References
– [1]Thomas J. Nelson, et al. Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases. WO2015058191A1.
CAS Number
– 56687-67-3
Molecular Weight
– 322.53
Compound Purity
– 98.0
SMILES
– O=C(OC)CCCCCCCC1C(CC2C(CCCCC)C2)C1
Clinical Information
– No Development Reported
Research Area
– Neurological Disease
Solubility
– DMSO : 15.62 mg/mL (ultrasonic)
Target
– PKC
Isoform
– PKCε
Pathway
– Epigenetics;TGF-beta/Smad
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.